Xukun Liu

机构：Liaocheng People's Hospital, Shandong First Medical University · ORCID：0000-0002-8501-5177

发表论文 31 篇 · 总被引 1027 次 · h-index 18

代表论文

• Oxidative Stress in Autism Spectrum Disorder—Current Progress of Mechanisms and Biomarkers (2022 · Frontiers in Psychiatry · 被引 204)
• Biomarkers in autism spectrum disorders: Current progress (2019 · Clinica Chimica Acta · 被引 124)
• Insights into predicting diabetic nephropathy using urinary biomarkers (2020 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 被引 94)
• Autism spectrum disorder: pathogenesis, biomarker, and intervention therapy (2024 · MedComm · 被引 77)
• Synthesis of gold nanorods and their performance in the field of cancer cell imaging and photothermal therapy (2021 · Cancer Nanotechnology · 被引 60)
• Se-Methylselenocysteine (SMC) Improves Cognitive Deficits by Attenuating Synaptic and Metabolic Abnormalities in Alzheimer’s Mice Model: A Proteomic Study (2021 · ACS Chemical Neuroscience · 被引 41)